4.7 Article

Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Mitochondrial arginase II constrains endothelial NOS-3 activity

Hyun Kyo Lim et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Article Endocrinology & Metabolism

Ornithine deficiency in the arginase double knockout mouse

Joshua L. Deignan et al.

MOLECULAR GENETICS AND METABOLISM (2006)

Article Multidisciplinary Sciences

Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism

J Steppan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Cardiac & Cardiovascular Systems

Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization

PH McNulty et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)

Review Hematology

Rho-kinase is an important therapeutic target in cardiovascular medicine

H Shimokawa et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Adenovirus-mediated gene transfer into the brain stem to examine cardiovascular function: role of nitric oxide and Rho-kinase

Y Hirooka

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Arginase pathway in human endothelial cells in pathophysiological conditions

T Bachetti et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)

Article Pharmacology & Pharmacy

Contractile responses of aortae from WKY and SHR to vasoconstrictors

G Gendron et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)

Article Physiology

Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells

LG Chicoine et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)

Article Pharmacology & Pharmacy

How could aortic arginase activity enhancement be involved in DOCA-salt hypertension?

S Rodriguez et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)

Article Neurosciences

Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57Bl/6J control mice

BN Van Vliet et al.

JOURNAL OF PHYSIOLOGY-LONDON (2003)

Article Biochemistry & Molecular Biology

Mouse model for human arginase deficiency

RK Iyer et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)

Article Peripheral Vascular Disease

Decreased expression of arginase II in the kidneys of Dahl salt-sensitive rats

S Iwata et al.

HYPERTENSION RESEARCH (2002)

Article Engineering, Biomedical

Comparing spectral and invasive estimates of baroreflex gain

GA Head et al.

IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE (2001)

Article Biochemistry & Molecular Biology

Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene

O Shi et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)

Article Endocrinology & Metabolism

Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells

H Li et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)

Article Neurosciences

Sympathetic activity in the rat: effects of anaesthesia on noradrenaline kinetics

E Maignan et al.

JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM (2000)

Article Pharmacology & Pharmacy

Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats

S Rodriguez et al.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2000)